Product Description
The Transmucosal Drug Delivery market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Transmucosal Drug Delivery market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Transmucosal Drug Delivery Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Transmucosal Drug Delivery market are:
Zosano Pharma
Apricus BioSciences, Inc
Pantec Biosolutions AG
Generex Biotechnology Corporation
Acrux Limited
Antares Pharma, Inc.
Tesa Labtec GmbH
Corium International, Inc
3M Pharmaceuticals
Aveva Drug Delivery Systems
MedPharm LTD
Noven Pharmaceuticals, Inc.
Tapemark
DURECT Corporation
Nitto Denko Corporation
Inovio Pharmaceuticals, Inc.
TEVA Pharmaceutical Industries Ltd.
Nemaura Pharma Ltd
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
ALZA Corporation
Mylan, Inc.
Most important types of Transmucosal Drug Delivery products covered in this report are:
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Most widely used downstream fields of Transmucosal Drug Delivery market covered in this report are:
Clinics
Hospitals
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.